India's Orchid Chemicals & Pharmaceuticals Ltd said on Monday that US-based Apotex Corporation would sell its generic cephalosporins and other injectible antibiotics in the United States.\n\n\n\n
New drug discovery and contract research have taken a back seat as global drug majors have slowed down their research and development offshoring to India.
Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga
BSE Mid-cap index ended at a record closing high of 10499.86 and CNX Mid-cap index ended at a record closing high of 12672.85 levels.
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
The 30-share Sensex provisionally ended up 112 points at 28,555 and the 50-share Nifty closed 24 points higher at 8,561 after hitting a record high of 8,626.95.
The Sensex ended down 251 points at 27,351 and the Nifty shed 65 points to close at 8,228.
Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter